News

Sinovac secures $15 million in funding to accelerate COVID-19 vaccine development

Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development to further the development of an inactivated vaccine against COVID-19 named CoronaVac.

Read More

May 25, 2020

By : Team ABLE

GSK partners Samsung Biologics to secure additional biopharmaceuticals manufacturing capacity

Samsung Biologics will provide GSK with additional capacity for large-scale biopharmaceutical product manufacturing.

Read More

May 25, 2020

By : Team ABLE

AstraZeneca gets ready to make 400 million doses of Oxford COVID-19 Vaccine

The company has concluded the first agreements for at least 400 million doses and has secured total manufacturing capacity for one billion doses so far and will begin first deliveries in September 2020.

Read More

May 22, 2020

By : Team ABLE

Bharat Biotech, Thomas Jefferson University to co-develop Covid-19 vaccine

Bharat Biotech will be involved in an end-to-end development of the vaccine, including comprehensive clinical trials to achieve commercial licence.

Read More

May 22, 2020

By : Team ABLE

Dr Harsh Vardhan is the new WHO Executive Board Chairman

Dr Harsh Vardhan takes over from Dr Hiroki Nakatani of Japan, the current Chairman.

Read More

May 22, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights